During the recent session, Gossamer Bio Inc (NASDAQ:GOSS)’s traded shares were 10.2 million, with the beta value of the company hitting 1.89. At the last check today, the stock’s price was $1.02, reflecting an intraday gain of 42.76% or $0.31. The 52-week high for the GOSS share is $1.60, that puts it down -56.86 from that peak though still a striking 50.98% gain since the share price plummeted to a 52-week low of $0.50. The company’s market capitalization is $230.53M, and the average intraday trading volume over the past 10 days was 1.47 million shares, and the average trade volume was 1.02 million shares over the past three months.
Gossamer Bio Inc (GOSS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.44. GOSS has a Sell rating from 0 analyst(s) out of 10 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.17.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Gossamer Bio Inc (GOSS) registered a 42.76% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 42.76% in intraday trading to $1.02, hitting a weekly high. The stock’s 5-day price performance is 42.22%, and it has moved by 19.99% in 30 days. Based on these gigs, the overall price performance for the year is -1.23%. The short interest in Gossamer Bio Inc (NASDAQ:GOSS) is 6.38 million shares and it means that shorts have 6.29 day(s) to cover.
The consensus price target of analysts on Wall Street is $4, which implies an increase of 74.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2 and $5 respectively. As a result, GOSS is trading at a discount of -390.2% off the target high and -96.08% off the low.
Gossamer Bio Inc (GOSS) estimates and forecasts
Statistics show that Gossamer Bio Inc has outperformed its competitors in share price, compared to the industry in which it operates. Gossamer Bio Inc (GOSS) shares have gone up 96.88% during the last six months, with a year-to-date growth rate more than the industry average at 76.27% against 17.10.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 6.83M as predicted by 8 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to 3.56M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 11.99%. While earnings are projected to return 76.09% in 2024, the next five years will return 5.20% per annum.
GOSS Dividends
Gossamer Bio Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders
Gossamer Bio Inc insiders own 3.33% of total outstanding shares while institutional holders control 77.46%, with the float percentage being 80.13%. NEA MANAGEMENT COMPANY, LLC is the largest shareholder of the company, while 112.0 institutions own stock in it. As of 2024-06-30, the company held over 18.09 million shares (or 8.0152% of all shares), a total value of $16.3 million in shares.
The next largest institutional holding, with 13.31 million shares, is of ARTAL GROUP S.A.’s that is approximately 5.8958% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $11.99 million.
Also, the Mutual Funds coming in first place with the largest holdings of Gossamer Bio Inc (GOSS) shares are Fidelity Select Portfolios – Biotechnology and Vanguard Total Stock Market Index Fund. Data provided on Oct 31, 2024 indicates that Fidelity Select Portfolios – Biotechnology owns about 7.91 shares. This amounts to just over 3.49 percent of the company’s overall shares, with a $8.03 million market value. The same data shows that the other fund manager holds slightly less at 7.84, or about 3.46% of the stock, which is worth about $7.96 million.
